LiDCO Group Plc develops, manufactures, and sells cardiac monitoring equipment in the United Kingdom, the United States, Continental Europe, Japan, and internationally. The company offers LiDCOplus, a computer-based platform monitor, which is used in the intensive care unit for real-time continuous display of hemodynamic parameters, such as cardiac output, oxygen delivery, and fluid-volume responsiveness; and LiDCOrapid, a cardiac output monitor for use in the operating theatre and peri-operative arenas for fluid and drug management. It also provides LiDCOview, an easy-to-use graphical display of historical hemodynamic data that is used for research and education purposes; and LiDCOunity, a monitoring system, which enables customers to have seamless monitoring from the emergency department to the intensive care unit, and the operating room to high dependency units. The company sells its products through direct sales and a network of distributors. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolLON:LID
CUSIPN/A
Phone+44-20-77491500
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-25.80%
Return on Equity-20.64%
Return on Assets-17.53%
Miscellaneous
EmployeesN/A
Outstanding Shares244,170,000
Lidco Group (LON:LID) Frequently Asked Questions
What is Lidco Group's stock symbol?
Lidco Group trades on the London Stock Exchange (LON) under the ticker symbol "LID."
What price target have analysts set for LID?
1 analysts have issued 12 month target prices for Lidco Group's stock. Their predictions range from GBX 14 to GBX 14. On average, they anticipate Lidco Group's stock price to reach GBX 14 in the next twelve months. View Analyst Ratings for Lidco Group.
Who are some of Lidco Group's key competitors?
Who are Lidco Group's key executives?
Lidco Group's management team includes the folowing people:
- Mr. Matthew G. Sassone, CEO & Director
- Dr. David M. Band, Co-Founder and Member of Clinical Advisory Board
- Ms. Jill McGregor, CFO, Company Sec. & Director
- Mr. Shane Doorish, Head of North America
- Ms. Kerin Williams, Company Sec.
Has Lidco Group been receiving favorable news coverage?
Media stories about LID stock have trended positive on Tuesday, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lidco Group earned a media sentiment score of 0.30 on Accern's scale. They also assigned news stories about the company an impact score of 45.25 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Lidco Group?
Shares of LID and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Lidco Group's stock price today?
One share of LID stock can currently be purchased for approximately GBX 7.25.
How big of a company is Lidco Group?
Lidco Group has a market capitalization of £12.93 million.
How can I contact Lidco Group?
Lidco Group's mailing address is 16 Orsman Road, LONDON, N1 5QJ, United Kingdom. The company can be reached via phone at +44-20-77491500.
MarketBeat Community Rating for Lidco Group (LID)
MarketBeat's community ratings are surveys of what our community members think about Lidco Group and other stocks. Vote "Outperform" if you believe LID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LID will underperform the S&P 500 over the long term. You may vote once every thirty days.
